NEWS RELEASENews Release Dated September 29, 2022
Company: Japan System Techniques Co., Ltd.
Representative: Takeaki Hirabayashi, President and CEO
Stock code: 4323, Tokyo Stock Exchange, Prime Market
Contact: Toshinori Hamada, General Manager ofPlanning & Administration Division
Tel: +81-6-4560-1000

Notice of Establishment of Business Alliance with IQVIA Solutions Japan
Japan System Techniques Co., Ltd. (JAST) has started a business alliance concerning joint activities involving thehealthcare business with IQVIA Solutions Japan K.K. (Head office: Minato-ku, Tokyo; President: Fumihiko Ugajin), asubsidiary of IQVIA Holdings Inc. (IQVIA), which is based in the United States and has operations worldwide.
The earnings forecast announced on May 13, 2022 already incorporates the effect of this matter on the results ofoperations for the fiscal year ending March 2023. An announcement will be made promptly if there is any additional
information that should be disclosed.

NEWS RELEASE

September 29, 2022
Japan System Techniques Co., Ltd.

Notice of Establishment of Business Alliance with IQVIA Solutions Japan
Japan System Techniques Co., Ltd. (JAST) has started a business alliance concerning joint activities involving the healthcare
business with IQVIA Solutions Japan K.K. (Head office: Minato-ku, Tokyo; President: Fumihiko Ugajin), a subsidiary of
IQVIA Holdings Inc. (IQVIA), which is based in the United States and has operations worldwide.
1. Background and purpose of the alliance

IQVIA is one of the world’s leading organizations for the provision to companies in the life sciences sector of advanced
analytic services, technologies for innovations and clinical trial services. Products and services support the clinicaldevelopment and commercialization of revolutionary treatments that improve outcomes for patients. Another strength isthe creation of intelligent connections by leveraging extensive knowledge and insight that can be used rapidly and revised
to reflect a variety of changes. IQVIA has a workforce of about 82,000 in more than 100 countries and regions. The
operations of IQVIA Solutions Japan are primarily in Japan.
JAST used ICT expertise acquired over many years to develop JMICS (JAST Medical Insurance Checking System),
which started in August 2010. This system speeds up and automates the inspections and analysis of monthly invoices for
medical services that are sent by healthcare institutions to patients. In addition, JAST used JMICS as the base for thelaunch in April 2013 of a medical big data business. To be a provider of data health solutions, this business covers abroad range of activities including the utilization of health checkup and other external data, many types of analysis andnotification services, and other services.
JAST creates services with the goals of converting medical data to an asset with value and of using ICT for the digitaltransformation of the business procedures of insurers. The company’s mission is to use these services to extend thehealthy life spans of the public and support health insurance for the people of Japan. Operations include the analysis of
medical expenses and business consulting for the health insurance. There are also operations extending from notifications
to a variety of guidance for staying healthy in order to encourage people to alter their behavior to improve their health.
These capabilities allow JAST to provide one-stop support for the data health plans of health insurers. JAST provides
services to more than 300 health insurance organizations throughout Japan, including local governments, healthinsurance societies and other types of insurers.
The Future Co-creation Laboratory of JAST builds and provides medical big data by using health insurance invoice andhealth checkup data, all of which is anonymous, of more than 8 million people. The lab works with healthcare companies
to develop new products and with universities for joint research projects. Activities of the lab are aimed at playing a rolein solving a diverse array of social issues involving healthcare and staying healthy.
The business alliance is expected to facilitate the effective utilization of the services, knowledge and accomplishmentsof both companies in the medical big data sector. Strengthening and creating services for leading a healthy life style andensuring a suitable level of expenses for healthcare is one goal. Another goal of the alliance is to make an even greater
contribution to solving social issues in the healthcare sector.
2. Outline of the business alliance
JAST and IQVIA Solutions Japan have reached an agreement regarding the following activities concerning the businessalliance. The two companies will continue to hold discussions for the purpose of using this alliance to achieve the above goals.

1NEWS RELEASE The data utilization sector
The medical big data of JAST and IQVIA will be combined in order to use the knowledge and experience of thesecompanies for the creation and provision of new services and solutions by using a database encompassing more than
13 million individuals.
Profile of IQVIA Solutions Japan

Name:Address:Representative:Established:
Business:ＵＲＬ:IQVIA Solutions Japan K.K.
Keikyu Daiichi Building,
4-10-18 Takanawa, Minato-ku, Tokyo
Fumihiko Ugajin, President
December 1964
The stock of parent company IQVIA Holdings is listed on the New York Stock
Exchange (Symbol: IQV). IQVIA is one of the world’s leading organizations for theprovision to companies in the life sciences sector of advanced analytic services,
technologies for innovations and clinical trial services. The company specializes in theprovision of practical insight. IQVIA Solutions Japan operates businesses of IQVIA in
Japan as part of the IQVIA group of companies in Japan. Major activities involve
medical data, technology solutions and consulting.
www.iqvia.co.jp■ Inquiries
Japan System Techniques Co., Ltd.
Healthcare Innovation Business Division
JMICS Solution Department, Business Strategy Office
TEL: +81-3-6718-2785
E-mail：jmics-sales@jast.co.jp
URL：https://jmics.jp/2